BRANFORD, Conn., Nov. 26 /PRNewswire-FirstCall/ -- CuraGen Corporation (Nasdaq: CRGN), a clinical-stage biopharmaceutical company focused on oncology, announced today that Dr. Timothy M. Shannon, President and Chief Executive Officer, will present a corporate update at the 19th Annual Piper Jaffray Health Care Conference on Wednesday, November 28, 2007, at 3:00 p.m. Eastern time. The conference is being held at The Pierre Hotel in New York, NY.
Access to a live webcast of the presentation will be available from the Investor Relations section of CuraGen's website at http://www.curagen.com. A replay of the webcast will be available after the presentation and archived for 30 days thereafter.
CuraGen Corporation (Nasdaq: CRGN) is a dedicated clinical-stage
biopharmaceutical company developing diverse approaches for the treatment
of cancer including the histone deacetylase inhibitor, belinostat, and the
antibody-drug conjugate, CR011-vcMMAE. By leveraging drug development
strengths cultivated over the years, CuraGen expects to make a difference
by advancing its promising therapeutics to address the unmet medical needs
of cancer patients. CuraGen Corporation is headquartered in Branford,
Connecticut. For additional information please visit http://www.curagen.com.
Glenn Schulman, Pharm.D.
Director of Investor Relations
|SOURCE CuraGen Corporation|
Copyright©2007 PR Newswire.
All rights reserved